Frequency News and Research

RSS

Consultation on the protection of patients and volunteers undergoing MRI examinations

The Health Protection Agency has published a consultation document on its website about the protection of patients and volunteers undergoing magnetic resonance imaging (MRI) examinations.

1 Nov 2007

Researchers show evidence of 'memory' in cells and molecules

Research to be reported October 29 in the journal Proceedings of the National Academy of Sciences (PNAS) provides evidence that some molecular interactions on cell surfaces may have a "memory" that affects their future interactions.

29 Oct 2007

New magnetic separation 'traveling wave magnetophoresis' might detect multiple pathogens at once

A magnetic separation technique developed by researchers at Duke University's Pratt School of Engineering and Purdue University makes it relatively simple to sort through beads hundreds of times smaller than the period at the end of this sentence.

29 Oct 2007

Higher radiation doses over shorter periods of time for prostate cancer doesn't lead to sexual dysfunction

Recent advances in the delivery of radiation therapy for prostate cancer are fueling a new trend of providing higher radiation doses over shorter periods of time.

29 Oct 2007

Lower frequency deep brain stimulation effective treatment for dystonia

A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.

25 Oct 2007

The cost of having a baby

The cost of having a baby, from the first prenatal visit to the baby's delivery, averaged roughly $7,600 for an uncomplicated birth, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

25 Oct 2007

Anticoagulant bivalirudin following angioplasty in heart attack patients reduces adverse events and bleeding

Late-breaking data presented at TCT 2007, the scientific symposium of the Cardiovascular Research Foundation (CRF), show that the use of the anticoagulant bivalirudin following angioplasty in heart attack patients reduces net adverse clinical events by 24 percent compared to the standard treatment, and significantly reduces major bleeding that occurs after angioplasty by 40 percent.

24 Oct 2007

Sounds can alter how masculine or feminine a person looks

Think about the confused feelings that occur when you meet someone whose tone of voice doesn't seem to quite fit with his or her gender.

24 Oct 2007

Most parents ignorant to teenager's substance use

New research results from the University at Buffalo's Research Institute on Addictions (RIA) suggest that most parents are aware of and accurately evaluate the extent of their teenager's cigarette smoking, marijuana use, drinking and overall substance use.

24 Oct 2007

Protecting health from climate change

As momentum for action on climate change continues to grow, the World Health Organization (WHO) announced today that it will focus its World Health Day 2008 theme on “protecting health from climate change.”

24 Oct 2007

SPIRIT III trial shows fewer major adverse cardiac events

Late breaking results from the SPIRIT III trial, presented at TCT 2007, the annual scientific symposium of the Cardiovascular Research Foundation, show that after 12 months, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent.

24 Oct 2007

Breakfast cereal helps prevent heart failure

New research suggests that men who eat more whole grain breakfast cereals reduce their risk of heart failure.

23 Oct 2007

New method of oral insulin delivery patented

Syracuse University researchers have designed, tested and patented a new method of oral insulin delivery that can potentially help reduce daily insulin injections for millions of people with diabetes who require therapy for optimal glycemic control.

22 Oct 2007

40 percent of men and 30 percent of women are overweight

A new global study revealed that 40 percent of men and 30 percent of women are overweight, while 24 percent of men and 27 percent of women are obese, researchers reported in Circulation: Journal of the American Heart Association.

22 Oct 2007

Coronary heart disease and women

Women who eat a healthy diet, drink moderate amounts of alcohol, are physically active, maintain a healthy weight and do not smoke have a significantly reduced risk of heart attack, according to a report in the October 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

22 Oct 2007

Whole grain breakfast cereals may reduce risk of heart failure in men

Men who consume a higher amount of whole grain breakfast cereals may have a reduced risk of heart failure, according to a report in the October 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

22 Oct 2007

Benefit of exenatide has not yet been proven

Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta), which is marketed by the manufacturer Eli Lilly.

18 Oct 2007

Breakbone fever a growing public health threat

Dengue fever, known as “breakbone fever” because of the excruciating back and joint pain that accompanies this infectious disease, is a growing public health threat for people living in tropical countries, as well as travelers to destinations such as Thailand, Brazil and Puerto Rico, according to research being presented at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH), Nov. 4-7.

17 Oct 2007

Strain of the bacteria Streptococcus pneumoniae that causes ear infections emerges; resistant to antibiotics, pneumococcal vaccine

A strain of the bacteria Streptococcus pneumoniae, which can cause ear infections in children, has been detected that is resistant to all FDA-approved antibiotics for treatment of ear infections and is not covered by the pneumococcal 7-valent conjugate vaccine, according to a study in the October 17 issue of JAMA.

17 Oct 2007

Study evaluates safety, efficacy and tolerability of probiotics for irritable bowel syndrome

A new analysis of randomized controlled trials evaluating probiotics in the treatment of irritable bowel syndrome (IBS) has found that Bifantis, Bifidobacterium infantis 35624, the sole ingredient in Align (manufactured by Procter & Gamble), is the only probiotic currently able to demonstrate significant improvement in IBS symptoms based upon a properly designed research study.

16 Oct 2007